7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The clinical management of high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) is challenging due to disease heterogeneity, illustrating the need for reliable biomarkers facilitating patient stratification and guiding treatment decisions. FMS-like tyrosine kinase 3 ligand (Flt3L) is emerging as a prognostic or predictive surrogate marker of host tumoral immune response and might enable the stratification of patients with otherwise comparable tumor features.

          Related collections

          Author and article information

          Journal
          Cancers (Basel)
          Cancers
          MDPI AG
          2072-6694
          2072-6694
          Sep 04 2021
          : 13
          : 17
          Affiliations
          [1 ] Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
          [2 ] Knowledge Management in Bioinformatics, Institute for Computer Science, Humboldt-Universität zu Berlin, 12489 Berlin, Germany.
          [3 ] Institute of Pathology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
          [4 ] German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
          [5 ] Department of Surgery, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
          [6 ] Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine, University Düsseldorf, 40225 Düsseldorf, Germany.
          [7 ] Max Delbrück Center for Molecular Medicine, Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany.
          Article
          cancers13174463
          10.3390/cancers13174463
          8430927
          34503273
          a021aace-7f1a-4712-9855-24ff518ae879
          History

          neuroendocrine neoplasm,cytokine,circulating biomarker,Flt3L,immuno-oncology,tumor microenvironment

          Comments

          Comment on this article

          Related Documents Log